Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.
about
Smoking cessation interventions for smokers with current or past depressionOpioid antagonists for smoking cessationInterventions for preventing weight gain after smoking cessationInterventions for preventing weight gain after smoking cessationOpioid antagonists for smoking cessationSystematic review and meta-analysis of opioid antagonists for smoking cessationEmerging drugs for the treatment of tobacco dependence: 2014 updateRacial differences in eligibility and enrollment in a smoking cessation clinical trialEndogenous opiates and behavior: 2006Smoking- and menstrual-related symptomatology during short-term smoking abstinence by menstrual phase and depressive symptomsPharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Acute HPA axis response to naltrexone differs in female vs. male smokers.Gender differences in associations between lifetime alcohol, depression, panic disorder, and posttraumatic stress disorder and tobacco withdrawal.Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates?Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch.Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration.A Critical Review of the Effects of Nicotine and Alcohol Coadministration in Human Laboratory Studies.Design of a comparative effectiveness evaluation of a culturally tailored versus standard community-based smoking cessation treatment program for LGBT smokers.Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessationRace and sex associations to weight concerns among urban African American and Caucasian smokersInfluence of δ-opioid receptors in the behavioral effects of nicotine.Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project.Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.Pharmacological Options for Smoking Cessation in Heavy-Drinking SmokersPast major depression and smoking cessation outcome: a systematic review and meta-analysis update.Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.Sex differences in the relationship between alcohol-associated smoking urge and behavior: a pilot study.Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokersDevelopment of a culturally targeted smoking cessation intervention for African American smokers.Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trialSmokers' Treatment Expectancies Predict Smoking Cessation Success.Endogenous opioid system: a promising target for future smoking cessation medications.Naltrexone: A Pan-Addiction Treatment?
P2860
Q24200330-777CDAF7-B533-4762-9BEC-CA2F3C79D0B5Q24202118-2E623F95-5756-4599-B883-BA82E8FBF8B5Q24203883-673674D0-61B9-4943-8808-C622CAB70436Q24241751-84CBD25F-CD02-4FED-AC4D-D7ACEAB8D770Q24243850-EEBBAFE9-BF4A-4A9A-8F25-C329F06EA513Q26853570-64E1DAAB-C375-44C8-8654-8197B459E92AQ28236453-B79A9B4F-19E9-4807-9424-A76C4235BD20Q28386905-9B6DE876-C133-48B8-99FB-B5D5B24DBC4CQ28752585-B0EF4857-9733-42C9-9421-2DCAF840AD00Q33566909-410BE32F-5751-4AC5-9291-F9EF9512827CQ33582063-14BBD8E3-2CE2-469F-88C3-B753F311E1DEQ33746448-029D754E-AC48-4A22-86BF-1DCBEF50B9DDQ33868647-E4A724EB-E78E-4034-B3DF-6FBF498EB51AQ33905960-32D2426C-2D2A-4477-9E7A-6B353D80A702Q34012381-14A32279-A41D-4A7E-AA20-C7550DFB4349Q34161014-3E54D8DD-4D9B-4BD1-BB0E-F10E33195559Q34167551-D81E7658-6B28-460D-B8D2-26769D86B388Q34482188-5871FF5C-926C-44BE-9038-2DD6BA37AFE7Q34552358-E20C0DBF-31E2-48D5-A748-97704A19A88BQ34729011-44B3F20E-EA6F-4995-B06A-3A83EBBF4B27Q35195302-9748A375-699F-4554-81AA-AAE87BC35087Q35689017-B13FA9E9-629C-4597-BDEA-A9792BD06C7BQ35785818-BF19E742-B65F-48DE-91C1-57679D0A51B8Q36108435-D74105EE-13D3-4314-A0EA-B4CE342984D5Q36174111-D865F725-F01C-47F0-A968-CD4344D00B9FQ36223647-A48065A0-8DB8-4B39-9E74-073CC2C4A384Q36253208-EED79A20-9A47-439A-83FE-41642D097EF8Q36267094-BD566B1E-3FA1-4F5E-9882-AD862CF115A3Q36294656-44575B66-220D-4207-9393-70C8C80FFD9EQ36670532-52E2EC77-D8B7-47DD-84D5-BD9899A04C15Q36774139-78A285A8-79C2-4533-8FEF-D4C5798F91E1Q36797159-C6118852-5F78-4C9C-B3A0-EB6E1315A5B3Q36842419-5E876F7A-5777-4F54-979D-3630E9191EEFQ36877440-9A60C156-0CCF-46CB-84B0-E318BEBCF72DQ37017326-C21DE499-208E-48BE-8485-3952B1D56065Q37167372-B90DF05A-570E-45B4-A2A5-F3C3965CAF16Q37179217-9097677F-35CF-4758-80F8-F4A52603DA34Q37221715-1C4D8E17-8809-4D6B-B70A-BA9C8CA1E8DDQ38747115-ED6ED470-D1A0-4AB6-A930-6CE35725B507Q38893069-602B4EB2-6B46-49EF-A6D5-571A45E36FBE
P2860
Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Efficacy of naltrexone in smok ...... xamination of sex differences.
@ast
Efficacy of naltrexone in smok ...... xamination of sex differences.
@en
Efficacy of naltrexone in smok ...... xamination of sex differences.
@nl
type
label
Efficacy of naltrexone in smok ...... xamination of sex differences.
@ast
Efficacy of naltrexone in smok ...... xamination of sex differences.
@en
Efficacy of naltrexone in smok ...... xamination of sex differences.
@nl
prefLabel
Efficacy of naltrexone in smok ...... xamination of sex differences.
@ast
Efficacy of naltrexone in smok ...... xamination of sex differences.
@en
Efficacy of naltrexone in smok ...... xamination of sex differences.
@nl
P2093
P50
P1476
Efficacy of naltrexone in smok ...... xamination of sex differences.
@en
P2093
Andrea King
Dingcai Cao
Roslynn C Riley
P304
P356
10.1080/14622200600789767
P577
2006-10-01T00:00:00Z